EVA1-Antibody Drug Conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells. Hou J, Uejima T, Tanaka M, Son YL, et al. Neuro Oncol 2024 Oct 29:noae226. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hou J, Uejima T, Tanaka M, Son YL, et al. EVA1-Antibody Drug Conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells. Neuro Oncol 2024 Oct 29:noae226. doi: 10.1093.
PMID: 39470407